ICD-10-CM Billable Code

N00.6

Acute nephritic syndrome with dense deposit disease

Clinical Classification Guidelines

Inclusion Terms

  • Acute nephritic syndrome with C3 glomerulopathy with dense deposit disease
  • Acute nephritic syndrome with membranoproliferative glomerulonephritis, type 2

Medical Intelligence & Overview

Acute nephritic syndrome with dense deposit disease is a rare kidney disorder characterized by inflammation of the glomeruli, the filtering units of the kidneys. This condition, classified under ICD-10 code N00.6, involves a specific form of glomerulonephritis associated with dense deposits seen in the kidney's structure. It is part of a broader group of conditions called C3 glomerulopathies, which are linked to abnormalities in the immune system's complement pathway, leading to kidney damage and impaired filtration function.

Causes & Symptoms

Clinical Causes: Dysregulation of the complement system leading to abnormal immune responses Genetic mutations affecting complement regulatory proteins Autoimmune processes that trigger immune complex formation and glomerular inflammation Secondary factors like infections or certain drugs that may stimulate immune activation Underlying systemic diseases that predispose to immune complex deposition

Key Symptoms: Hematuria (blood in the urine), often visible as dark or cola-colored urine Proteinuria (excess protein in urine), leading to frothy urine Edema, particularly around the eyes, ankles, or legs Hypertension (high blood pressure) Reduced urine output or oliguria General signs of kidney dysfunction such as fatigue or nausea Flank pain or discomfort in some cases Possible fever or signs of systemic inflammation depending on underlying cause

Diagnostic & Treatment

Diagnosis Path: Diagnosis typically involves a combination of laboratory tests and kidney biopsy. Key diagnostic steps include: - Urinalysis to detect blood and protein levels - Blood tests to measure kidney function (serum creatinine, blood urea nitrogen) - Complement levels testing (especially C3 and C4) to identify abnormalities - Kidney biopsy under imaging guidance, revealing characteristic dense deposit formations within glomeruli through electron microscopy - Additional tests to exclude other causes of nephritis or systemic disease

Treatment Protocols: Management of this condition aims to control inflammation, support kidney function, and prevent progression to kidney failure. Approaches may include: - Immunosuppressive medications such as corticosteroids - Drugs targeting the complement system to reduce abnormal immune activation - Blood pressure control with antihypertensive agents, especially ACE inhibitors or ARBs - Dietary modifications to reduce kidney workload - Regular monitoring of kidney function and urinary findings - In some cases, plasmapheresis or plasma exchange therapies may be used to remove pathogenic immune factors - Kidney support therapies like dialysis if kidney function declines significantly It is essential to collaborate with healthcare providers for personalized care tailored to disease severity and individual health status.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is N00.6 a billable ICD-10 code?
Yes, N00.6 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report N00.6?
Clinical documentation must specify the nature of Acute nephritic syndrome with dense deposit disease and any associated comorbidities for accurate reporting.

Cite this Clinical Reference

Clinical Meta Tags

acute dense syndrome nephritic disease deposit